Table of Contents
Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.2 Research Methodology
1.2.1 Information Procurement
1.2.1.1 Purchased Database:
1.2.1.2 Gvr’s Internal Database
1.2.2 Primary Research:
1.3 Research Scope And Assumptions
1.4 Research Methodology (Parent Market Approach And Commodity Flow Analysis)
1.4.1 Research Methodology Steps: Commodity Flow Approach
1.5 List Of Secondary Sources
1.6 List Of Primary Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Regional Insight
2.4 Competitive Insights
2.5 Artificial Intelligence (Ai) In Cancer Diagnostics Market Snapshot
2.6 Artificial Intelligence (Ai) In Cancer Diagnostics Segment Snapshot
2.7 Artificial Intelligence (Ai) In Cancer Diagnostics Segment Snapshot (Contd.)
2.8 Artificial Intelligence (Ai) In Cancer Diagnostics Competitive Snapshot
Chapter 3 Artificial Intelligence (Ai) In Cancer Diagnostics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.1.1 Ai In Healthcare Market
3.1.2 Related/Ancillary Market Outlook
3.1.2.1 Artificial Intelligence In Medical Imaging Market
3.2 Penetration And Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 Artificial Intelligence (Ai) In Cancer Diagnostics Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Early Detection And Classification Of Diseases
3.4.1.2 Early Detection And Classification Of Cancer
3.4.1.3 Increasing Use Of Ai In Chronic Disease Management
3.4.1.4 Increasing Number Of Startups & Collaborations And Growing Venture Capitalist Funding
3.4.2 Market Restraint Analysis
3.4.2.1 Highly Regulated Industry
3.4.2.2 Procurement Costs And Maintenance
3.5 Artificial Intelligence In Cancer Diagnostics Market Analysis Tools
3.5.1 Industry Analysis – Porter’s
3.5.1.1 Bargaining Power Of Suppliers -Moderate
3.5.1.2 Bargaining Power Of The Buyers – Low
3.5.1.3 Threat Of Substitution – Low
3.5.1.4 Threats Of New Entrants -Moderate
3.5.1.5 Competitive Rivalry – High
3.5.2 Pestel Analysis
3.5.2.1 Political And Legal Landscape
3.5.2.2 Economic And Social Landscape
3.5.2.3 Technology Landscape
3.6 Impact Of The Covid-19 Pandemic On Ai In Cancer Diagnostics Market
Chapter 4 Global Artificial Intelligence (Ai) In Diagnostics Market: Competitive Analysis
4.1 Company/Competition Categorization (Key Innovators, Market Leaders, & Emerging Players)
4.2 Recent Developments, By Key Market Participants
4.3 Company Market Position Analysis
Chapter 5 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Component Estimates & Trend Analysis
5.1 Segment Dashboard
5.2 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Component Analysis, 2022 & 2030 (USD Million)
5.3 Ai In Cancer Diagnostics Market, By Component, 2017 – 2030 (USD Million)
5.4 Software Solutions
5.4.1 Software Solutions Market Estimates And Forecasts, 2017 – 2030 (USD Million)
5.5 Hardware
5.5.1 Hardware Market Estimates And Forecasts, 2017 – 2030 (USD Million)
5.6 Services
5.6.1 Services Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 6 Artificial Intelligence (AI) In Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis
6.1 Segment Dashboard
6.2 Artificial Intelligence (AI) In Cancer Diagnostics Market: Cancer Type Analysis, USD Million, 2022 & 2030
6.3 AI In Cancer Diagnostics Market, By Cancer Type, 2017 – 2030 (USD Million)
6.4 Breast Cancer
6.4.1 Breast Cancer Market Estimates And Forecasts, 2017 – 2030 (USD Million)
6.5 Lung Cancer
6.5.1 Lung Cancer Market Estimates And Forecasts, 2017 – 2030 (USD Million)
6.6 Prostate Cancer
6.6.1 Prostate Cancer Market Estimates And Forecasts, 2017 – 2030 (USD Million)
6.7 Colorectal Cancer
6.7.1 Colorectal Cancer Market Estimates And Forecasts, 2017 – 2030 (USD Million)
6.8 Brain Tumor
6.8.1 Brain Tumor Market Estimates And Forecasts, 2017 – 2030 (USD Million)
6.9 Others
6.9.1 Others Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 7 Artificial Intelligence (Ai) In Cancer Diagnostics Market: End-User Estimates & Trend Analysis
7.1 Segment Dashboard
7.2 Artificial Intelligence (Ai) In Cancer Diagnostics Market: End-User Analysis, USD Million, 2022 & 2030
7.3 Ai In Cancer Diagnostics Market, By End-User, 2017 – 2030 (USD Million)
7.4 Hospitals
7.4.1 Hospitals Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.5 Surgical Centers And Medical Institutes
7.5.1 Surgical Centers And Medical Institutes Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.6 Others
7.6.1 Others Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 8 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Regional Estimates & Trend Analysis: By Component, Cancer Type, And End-User
8.1 Regional Market Key Takeaways
8.2 Regional Market Snapshot
8.3 Growing Global Cancer Prevalence
8.4 North America
8.4.1 North America Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.4.2 U.S.
8.4.2.1 U.S. Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.4.3 Canada
8.4.3.1 Canada Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5 Europe
8.5.1 Europe Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5.2 Uk
8.5.2.1 Uk Ai In Cancer Diagnostics Market Estimates And Forecasts, 2016 – 2030 (USD Million)
8.5.3 Germany
8.5.3.1 Germany Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5.4 France
8.5.4.1 France Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5.5 Italy
8.5.5.1 Italy Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5.6 Spain
8.5.6.1 Spain Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5.7 Russia
8.5.7.1 Russia Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.6.2 China
8.6.2.1 China Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.6.3 India
8.6.3.1 India Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.6.4 Japan
8.6.4.1 Japan Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.6.5 South Korea
8.6.5.1 South Korea Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.6.6 Australia
8.6.6.1 Australia Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.6.7 Singapore
8.6.7.1 Singapore AI IN Cancer Diagnostics MARKET Estimates And Forecasts, 2017 – 2030 (USD MILLION)
8.7 Latin America
8.7.1 Latin America Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil Ai In Healthcare Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.7.4 Argentina
8.7.4.1 Argentina Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.8 MEA
8.8.1 MEA Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.8.2 South Africa
8.8.2.1 South Africa Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.8.4 UAE
8.8.4.1 UAE Ai In Cancer Diagnostics Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Competition Categorization
9.3. Company Market Position Analysis
Chapter 10. Company Profiles
10.1.1 EarlySign
10.1.1.1 Overview
10.1.1.2 Financial Performance
10.1.1.3 Technology Benchmarking
10.1.1.4 Strategic Initiatives
10.1.2 Cancer Center.ai
10.1.2.1 Overview
10.1.2.2 Financial Performance
10.1.2.3 Technology Benchmarking
10.1.2.4 Strategic Initiatives
10.1.3 Microsoft
10.1.3.1 Overview
10.1.3.2 Financial Performance
10.1.3.3 Technology Benchmarking
10.1.3.4 Strategic Initiatives
10.1.4 Flatiron
10.1.4.1 Overview
10.1.4.2 Financial Performance
10.1.4.3 Technology Benchmarking
10.1.4.4 Strategic Initiatives
10.1.5 Path AI
10.1.5.1 Overview
10.1.5.2 Financial Performance
10.1.5.3 Technology Benchmarking
10.1.5.4 Strategic Initiatives
10.1.6 Therapixel
10.1.6.1 Overview
10.1.6.2 Financial Performance
10.1.6.3 Technology Benchmarking
10.1.6.4 Strategic Initiatives
10.1.7 Tempus
10.1.7.1 Overview
10.1.7.2 Financial Performance
10.1.7.3 Technology Benchmarking
10.1.7.4 Strategic Initiatives
10.1.8 Paige AI Inc.
10.1.8.1 Overview
10.1.8.2 Financial Performance
10.1.8.3 Technology Benchmarking
10.1.8.4 Strategic Initiatives
10.1.9 Kheiron Medical Technologies Limited Overview
10.1.9.1 Financial Performance
10.1.9.2 Technology Benchmarking
10.1.9.3 Strategic Initiatives
10.1.10 SkinVision
10.1.10.1 Overview
10.1.10.2 Financial Performance
10.1.10.3 Technology Benchmarking
10.1.10.4 Strategic Initiatives
TABLE 1 Global cancer incidence, 2020
TABLE 2 Number of new cases of cancer, by country
TABLE 3 U.S. macro dynamics
TABLE 4 Canada macro dynamics
TABLE 5 Number of new cases of cancer, by country
TABLE 6 UK macro dynamics
TABLE 7 Germany macro dynamics
TABLE 8 France macro dynamics
TABLE 9 Italy macro dynamics
TABLE 10 Spain macro dynamics
TABLE 11 Russia macro dynamics
TABLE 12 Number of new cases of cancer, by country
TABLE 13 China macro dynamics
TABLE 14 India macro dynamics
TABLE 15 Japan macro dynamics
TABLE 16 South Korea Macro dynamics
TABLE 17 Australia macro dynamics
TABLE 18 Singapore macro dynamics
TABLE 19 Number of new cases of cancer, by country
TABLE 20 Brazil macro dynamics
TABLE 21 Mexico macro dynamics
TABLE 22 Argentina macro dynamics
TABLE 23 Number of new cases of cancer, by country
TABLE 24 South Africa macro dynamics
TABLE 25 Saudi Arabia macro dynamics
TABLE 26 UAE macro dynamics
TABLE 27 Key companies undergoing expansions
TABLE 28 Key companies undertaking acquisitions and mergers
TABLE 29 Key companies launching new products/services
TABLE 30 Key companies undertaking collaboration and partnership
TABLE 31 Key companies undertaking other strategies
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
